This protocol is judged by an institutional review board, an unbiased group that testimonials any scientific trials involving human beings. If a review requires a Agenda I drug, once the board approves the protocol as ethical, the scientists really need to apply for an investigational new drug (IND) number from the FDA.This article includes a list